CHARMD
Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database
English (en)
Français (fr)
Español (es)
CNR Website
Home
Login
Data
All data
Antivirals
Bibliography
Therapeutic targets
Tools
Search
Submit mutations
Request expertise
Genotyping tool
Gene maps
Contact
Notice
How to cite
Last update : Mon 20 Apr 2026
TOP
Rawlinson WD
References:
Rank: 3 -
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.(Jan 2007)
Rank: 5 -
Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.(Sep 2004)
Filter:
Mutant
Gene
Virus
Reference
Mutations:
N408K
UL54
Human betaherpesvirus 5
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates. (Jan 2007)
N408K
UL54
Human betaherpesvirus 5
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates. (Jan 2007)
N408K
UL54
Human betaherpesvirus 5
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates. (Jan 2007)
A834P
UL54
Human betaherpesvirus 5
Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations. (Sep 2004)
A834P
UL54
Human betaherpesvirus 5
Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations. (Sep 2004)
A834P
UL54
Human betaherpesvirus 5
Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations. (Sep 2004)
Tilloy
et al.
, 2024
Interdeposit Digital Number: IDDN.FR.001.420004.000.S.X.2024.000.31230